The invention discloses a novel technology for producing recombinant adeno associated viruses by means of 293-series
cell microcarrier cultivation and
virus packaging by the aid of WAVE type bioreactors in a
pilot test manner. The novel technology includes (1), cultivating cells, to be more specific, inoculating the 293-series cells onto microcarriers in
cell cultivation bags, adding cultivation media into the
cell cultivation bags and shaking the cultivation bags; (2), packaging viruses, to be more specific,
settling the microcarriers, adding fresh cultivation media,
transfection reagents and three-
plasmid systems for packaging the viruses to the cultivation bags, continuing to cultivate the cells after co-
transfection is carried out and packaging the viruses; (3), separating and purifying the viruses, to be more specific, collecting supernatant by means of centrifuging or suction
filtration or
filtration after the cells are completely cultivated, and separating and purifying the viruses by the aid of AKTA
protein and
nucleic acid chromatographic systems; (4), determining
titer of the viruses by the aid of Q-PCR (quantitative-
polymerase chain reaction) instruments. The novel technology has the advantages that the cells can be automatically cultivated on a large scale and can be transfected, the viruses can be packaged, the recombinant viruses can be produced in a
pilot test manner, requirements of the majority of scientific research users can be met, supply and demand contradiction on
virus and carrier markets can be relieved, and the labor cost input can be reduced.